Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of echinocandin concentrations in body fluids
2013-005065-38Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Dec 2013
- Modality
- Small Molecules, Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of caspofungin, micafungin and anidulafungin in invasive mycoses (3 arms), sponsored by Medical University of Innsbruck. Started Dec 2013; status: completed.
02
Drugs
caspofunginmicafunginanidulafungin
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2013-005065-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005065-38.